|
Volumn 113, Issue , 2014, Pages 394-402
|
Corrigendum to “Bio-responsive chitin-poly(l-lactic acid) composite nanogels for liver cancer” (Bio-responsive chitin-poly(l-lactic acid) composite nanogels for liver cancer (2014) 113 (394–402), (S0927776513005912), (10.1016/j.colsurfb.2013.09.023));Bio-responsive chitin-poly(l-lactic acid) composite nanogels for liver cancer
|
Author keywords
Chitin PLA composite nanogels; Doxorubicin; Drug delivery; Liver cancer; Nanomedicine
|
Indexed keywords
CELL CULTURE;
CHITIN;
DISEASES;
DRUG DELIVERY;
LACTIC ACID;
MEDICAL NANOTECHNOLOGY;
NANOSTRUCTURED MATERIALS;
TARGETED DRUG DELIVERY;
ANTI-CANCER DRUG DELIVERY;
BLOOD COMPATIBILITY;
CELLULAR INTERNALIZATION;
CHEMOTHERAPEUTIC AGENTS;
DOXORUBICIN;
FLUORESCENT MICROSCOPY;
LIVER CANCERS;
NANOGELS;
CONTROLLED DRUG DELIVERY;
CHITIN;
DOXORUBICIN;
NANOCARRIER;
POLYLACTIC ACID;
ARTICLE;
BIODEGRADABILITY;
BLOOD CLOTTING TEST;
BLOOD COMPATIBILITY;
CANCER CELL;
COMPOSITE MATERIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG DEGRADATION;
DRUG DELIVERY SYSTEM;
DRUG DOSAGE FORM COMPARISON;
DRUG ENTRAPMENT EFFICIENCY;
DRUG RELEASE;
DRUG UPTAKE;
GEL;
HEMOLYSIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
INFRARED SPECTROSCOPY;
INJECTION;
INTERNALIZATION;
LIVER CELL CARCINOMA;
NANOGEL;
PARTICLE SIZE;
PH;
PHARMACOLOGICAL PARAMETERS;
PRIORITY JOURNAL;
SCANNING ELECTRON MICROSCOPY;
CHITIN-PLA COMPOSITE NANOGELS;
DOXORUBICIN;
DRUG DELIVERY;
LIVER CANCER;
NANOMEDICINE;
CELL SURVIVAL;
CHITIN;
DOXORUBICIN;
HEMOLYSIS;
HEP G2 CELLS;
HUMANS;
LACTIC ACID;
LIVER NEOPLASMS;
NANOMEDICINE;
POLYETHYLENE GLYCOLS;
POLYETHYLENEIMINE;
POLYMERS;
|
EID: 84885455715
PISSN: 09277765
EISSN: 18734367
Source Type: Journal
DOI: 10.1016/j.colsurfb.2019.05.021 Document Type: Erratum |
Times cited : (41)
|
References (43)
|